Home

RAJESH C MD SHROTRIYA

CIK 1193918 · Chairman & CEO · last filed 2023-02-01

RAJESH C MD SHROTRIYA is a Chairman & CEO who has filed 83 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for GTBP, was dated Feb 1, 2023. Across all open-market trades the lifetime net is −$25.1M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

83

Lifetime Open-Market Net

-$25.12M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GTBP Director — $0.45 — $0 3 2023-02-01
CASI Pharmaceuticals, Inc. (CASI) Delisted Director — $0.28 — $0 9 2022-05-26
SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Director 1,292,041 $1.03 $1.33M -$25.12M 71 2018-05-17

Recent Filings

83 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-02-01 GTBP Grant (A) — $0 EDGAR
2022-07-19 GTBP Grant (A) — $0 EDGAR
2022-05-26 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2022-02-14 GTBP Grant (A) — $0 EDGAR
2021-06-16 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2020-06-18 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2019-06-21 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2018-07-03 CASI Pharmaceuticals, Inc. (CASI) Delisted Grant (A) — $0 EDGAR
2018-05-17 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Mixed +362,926 $529.0K EDGAR
2018-05-14 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Sell (S) −84,014 -$1.48M EDGAR
Showing 1–10 of 83
Page 1 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.